it's about providing the right medical guidance, ongoing support, and effective tools to ensure your path to weight loss is safe, sustainable, and successful
New results released this week from the SURMOUNT-5 clinical trial comparing tirzepatide (Zepbound) to semaglutide (Wegovy) are closely aligned to Truveta Researchs GLP-1 comparative effectiveness study, initially shared more than a year ago on November 27, 2023 and published earlier this year in JAMA Internal Medicine
this effect behaves much more like a reward-suppression state than a hormone deficiency
Lets take a look at the main ingredients and see what the studies do show, and what the connections are to GLP-1s
This observation often causes concern, particularly for patients new to injectable therapies
This "master antioxidant" is made from three simple amino acids but packs serious protective power